Navigate to Other Sector


Healthcare Newsletter – April 2017

Bleak Aftermath of Price Control Threatens Indian Patients’ Access to Innovative Devices and Drugs
Further Regulatory Clarity Drives Momentum in US Biosimilars Market
BD’s acquisition of CR Bard signifies Rapid Consolidation in Global Medical Devices Markets
Roche’s Ocrevus Poised to make a splash in Multiple Sclerosis Therapy

Sathguru in the News


CPhI North America 2017 (Philadelphia, USA – May 2017)
Meet us at CPhI North America (May 16-18, 2017), the leading global show for pharma ingredients

BIO 2017 (San Diego, CA – June 2017)
Look forward to meeting you at the beach or in the convention center (booth 4700). Sathguru’s CEO Vijay is moderating a penel on biologics in crop improvement.

Stop by to say hello to us!

Mandates—ongoing assignments and partnering opportunities

  1. In-licensing/Acquiring – ANDAs and specialty generics for leading Indian Pharma Company
  2. Strategic investments – Leading Israeli CDMO with strong expertise in topical products
  3. Private equity fund raising – Indian diagnostic company
  4. Series A VC fund raising – Pioneering health tech venture

Contact us to know more…

Discussion — No responses

Show Buttons
Hide Buttons